Topical tacrolimus therapy for localized bullous pemphigoid [3]

British Journal of Dermatology

Volumn 149, Issue 5, 2003, Pages 1079-1081

  Ko, M J ^a   Chu, C Y ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BUCLIZINE; DOXEPIN; ETHAMBUTOL; IMMUNOGLOBULIN G ANTIBODY; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TACROLIMUS; TUBERCULOSTATIC AGENT;

AGED; BLISTER; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; LETTER; LUNG TUBERCULOSIS; MALE; PEMPHIGOID; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY; SYMPTOM;

AGED; AGED, 80 AND OVER; HAND DERMATOSES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PEMPHIGOID, BULLOUS; TACROLIMUS;

EID: 0348012913     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05611.x     Document Type: Letter

References (10)

1. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000; 25: 250-4.
2. Reitamo S, Wollenberg A, Schopf E et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999-1006.
3. Paller A, Eichenfleld LF, Leung DYM et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 33: S47-57.
4. Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol 2002; 16: 100-14.
5. Walker SL, Kirby B, Chalmers RJG. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002; 147: 405-6.
6. Joly P, Roujeau JC, Benichou J et al. A comparison of oral and topical corticosterolds In patients with bullous pemphigoid. N Engl J Med 2002; 346: 321-7.
7. Wojnarowska F, Kirtschig G, Highet AS et al. Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002; 147: 214-21.
8. Budinger L, Borradori L, Yee C et al. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest 1998; 102: 2082-9.
9. Reinhard T, Reis A, Mayweg S et al. Topical FK506 in inflammatory corneal and conjunctival diseases. A pilot study. Klin Monatsbl Augenheilkd 2002; 219: 125-31.
10. John RS. Bullous pemphigoid. In: Dermatology in General Medicine (Freedberg IM, Eisen AZ, Wolff K et al., eds), 5th edn. Vol. 1. New York: McGraw-Hill, 1999: 666-73.